These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5379940)

  • 21. Use of cell cultures in vaccine production: diploid and stable cell cultures.
    Matchett A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
    [No Abstract]   [Full Text] [Related]  

  • 22. Tissue and medium antigens in vaccines--discussion.
    Feldman HA
    Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791
    [No Abstract]   [Full Text] [Related]  

  • 23. The large-scale cultivation of diploid cell strains in microcarrier culture. Improvement of microcarriers.
    van Wezel AL
    Dev Biol Stand; 1976 Dec 13-15; 37():143-7. PubMed ID: 1031679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CIR (cell injuring reaction) active substances in culture fluid of Bacillus cereus "MS-1063 strain".
    Tanaka J; Shimizu R; Hatano M
    Jpn J Med Sci Biol; 1970 Oct; 23(5):336-9. PubMed ID: 4993666
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of diploid cell lines as a multiplication substrate for viral vaccine production].
    Welke G
    Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390
    [No Abstract]   [Full Text] [Related]  

  • 26. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Jensen KE
    Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccine production as a unit process.
    van Hemert P
    Prog Ind Microbiol; 1974; 13():151-271. PubMed ID: 4373785
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cultivation of foot-and-mouth disease virus type O in tissue cultures and utilization of its mutability for the production of new vaccine strains].
    Mitev G; Tekerlekov P
    Arch Exp Veterinarmed; 1966 Mar; 20(1):91-7. PubMed ID: 4293437
    [No Abstract]   [Full Text] [Related]  

  • 29. The choice of the cell substrate for human virus vaccine production.
    Hayflick L
    Lab Pract; 1970 Jan; 19(1):58-62. PubMed ID: 4984599
    [No Abstract]   [Full Text] [Related]  

  • 30. Comments on use of cell cultures in vaccine production.
    Kniazeff AJ
    J Am Vet Med Assoc; 1970 Jun; 156(12):1795-7. PubMed ID: 5422528
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of standardized cell substrates as an alternative to primary animal tissue for vaccine production.
    Perkins FT
    Proc R Soc Med; 1970 Oct; 63(10):985-6. PubMed ID: 5483522
    [No Abstract]   [Full Text] [Related]  

  • 32. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Vasington PJ
    Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous immunization of cattle and with strain 19 Brucella abortus and infectious bovine rhinotracheitis (IBR) vaccines.
    Smith BF; Fastier LB
    N Z Vet J; 1965 Feb; 13(1):21. PubMed ID: 5212981
    [No Abstract]   [Full Text] [Related]  

  • 34. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Fellowes ON
    Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
    [No Abstract]   [Full Text] [Related]  

  • 35. Improvement of foot-and-mouth disease vaccine of Frenkel origin with the study of the immunogen virus component made evident by arcton extraction.
    Girard HC; Erol N; Ilerle M
    Bull Off Int Epizoot; 1969; 71(3-4):307-40. PubMed ID: 4323523
    [No Abstract]   [Full Text] [Related]  

  • 36. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 37. A perfusion culture system for virus vaccine manufacture in diploid cell cultures.
    Mann GF; de Mucha Macías J
    Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of a lethality factor from virulent cultures of coagulase-forming staphylococci].
    Anatoliĭ SA; Repin VS; Klenin SI; Logunov AM; Osipova TN
    Biokhimiia; 1971; 36(4):723-6. PubMed ID: 5095957
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recent data on the problem of rubella].
    Sorodoc Y
    Stud Cercet Inframicrobiol; 1971; 22(1):53-85. PubMed ID: 4935750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of BHK-21 culture in suspensions for the multiplication of aphthous fever virus and the preparation of aphthous fever vaccines].
    Guilloteau B; D'Oultremont PA; Guerche M; Legrand B; Prunet P
    Bull Off Int Epizoot; 1969; 71(1-2):97-120. PubMed ID: 4315035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.